SCHEMBL8820451

SCHEMBL8820451

O=[N+]([O-])c1ccc(O)c(S(=O)(=O)Nc2ccccc2)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA2 P00918 3/20 0.61
▸ CA12 O43570 1/20 0.61
▸ CA9 Q16790 1/20 0.61
▸ BCL2L1 Q07817 1/20 0.56
▸ MCL1 Q07820 1/20 0.56
▸ MAPT P10636 4/20 0.53
▸ MEN1 O00255 3/20 0.53
▸ KMT2A Q03164 3/20 0.53
▸ LMNA P02545 2/20 0.53
▸ SMN1; SMN2 Q16637 2/20 0.53
▸ MAPK1 P28482 1/20 0.53
▸ CXCR2 P25025 4/20 0.52
▸ CXCR1 P25024 3/20 0.52
▸ ALDH1A1 P00352 4/20 0.51
▸ GAA P10253 1/20 0.51
▸ HPGD P15428 1/20 0.51
▸ SLC25A1 P53007 1/20 0.50
▸ PGR P06401 1/20 0.48
▸ DDX3X O00571 1/20 0.48
▸ CA1 P00915 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23833717 0.86 CA2 (0.49) CA2CA12CA9BCL2L1MCL1
SCHEMBL11407805 0.84 CA2 (0.63) CA2CA12CA9BCL2L1MCL1
SCHEMBL10422318 0.83 SLC25A1 (0.66) CA2CA12CA9BCL2L1MCL1
SCHEMBL23832738 0.83 CA12 (0.61) CA2CA12CA9BCL2L1MCL1
SCHEMBL7572373 0.83 L3MBTL1 (0.67) CA2CA12CA9MAPTMEN1
SCHEMBL34474379 0.82 MYC (0.52) CA2CA12CA9MCL1MAPT
SCHEMBL7015594 0.81 GUSB (0.66) CA2CA12CA9BCL2L1MCL1
SCHEMBL2741009 0.81 CA2 (0.58) CA2CA12CA9BCL2L1MCL1
SCHEMBL25754684 0.80 HPGD (0.62) CA2CA12CA9MAPTMEN1
SCHEMBL2912639 0.78 CA2 (0.51) CA2CA12CA9MAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1997046520-A1 4-NITRO-2-PHENOXYSULFONANILIDE DERIVATIVES TAISHO PHARMACEUTICAL CO., LTD. (JP) 1997-12-11 — — WO disclosed
Send feedback